PALACE-DUBAI-CREEK
1.5.2024 11:51:26 CEST | Business Wire | Press release
Palace Dubai Creek Harbour Hotel by Emaar Hospitality Group has officially opened its doors in the centre of Dubai, presenting a blend of contemporary elegance and Arabian allure. With its premium waterside position on the Dubai Creek shoreline, the hotel boasts magnificent, unrestricted waterfront views and offers a refreshing take on the Dubai skyline. To celebrate the opening, special offers have been extended from May 1st to May 31st, 2024, including a 30% discount on the Best Available Rates and complimentary breakfast.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240430488407/en/
Palace Dubai Creek Harbour Hotel Officially Opens Its Doors in the Heart of Dubai (Photo: AETOSWire)
Nestled within Dubai Creek Harbour, an avant-garde waterfront district, Palace Dubai Creek Harbour provides guests with access to expansive parks, cultural spaces, and pedestrian-friendly streets, epitomising the zenith of modern urban planning. The hotel is conveniently located a 15-minute drive from Dubai International Airport, and it is also in close proximity to iconic landmarks such as Dubai Mall, Burj Khalifa, and downtown attractions. Connected to a major bridge, it blends convenience with serenity, perfect for travellers seeking both accessibility and peace.
The hotel’s enviable amenities include a striking rooftop infinity pool, spa services, and guest rooms with generous private balconies. Boasting 122 rooms, offering various options including suites, that are decked out with top-of-the-line furnishings and design details that evoke modern Arabian sophistication. The hotel’s interiors reflect opulent Arabesque décor, showcasing a synergy of heritage art pieces with contemporary architecture.
Palace Dubai Creek Harbour also offers an enticing dining experience at Fai Lounge, which offers a poolside vibe during the day and transforms into a chic evening venue. Guests can take pleasure in Levantine and Arabian flavors at familiar restaurants such as Ewaan and Al Bayt. These dining venues, complete with sumptuous indoor spaces and open-air terraces, aim to be the go-to destination throughout the year.
Designed for both leisure and business travellers, the property boasts a fully equipped 24/7 fitness centre, a vibrant Qix Club for kids, a Boardroom and a Business Centre. The spa offers a serene sanctuary, providing rejuvenating treatments for guests.
Palace Dubai Creek Harbour champions a luxurious experience that melds classical refinement with the latest in opulence, ensuring guests enjoy panoramic vistas of the city and the canal.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240430488407/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HistoSonics Receives Regulatory Approval in Singapore, Advancing Expansion Across Asia-Pacific2.11.2026 14:00:00 CET | Press release
HistoSonics today announced that the company has received market authorization from Singapore’s Health Sciences Authority (HSA) for its Edison® Histotripsy System (under the device name HistoSonics Histotripsy System), marking another significant milestone in the company’s continued international expansion and creating new opportunities to advance access to histotripsy throughout the Asia-Pacific region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261102090757/en/ HistoSonics Edison® Histotripsy System The Edison System is a novel, non-invasive, image-guided platform that uses the mechanical properties of focused ultrasound, known as histotripsy, to mechanically destroy and liquefy unwanted tissue and tumors. The technology offers a fundamentally new approach to tissue destruction without the need for invasive procedures, radiation, or thermal energy. The Edison System is currently authorized for the destruction of liver
NIQ Publishes 2026 ESG Progress Report, Highlighting Action Across Climate, People, Communities, and Responsible AI2.11.2026 12:45:00 CET | Press release
Report details NIQ’s continued focus on responsible business, including its first climate risk assessment, expanded employee development and more than 100,000 volunteer hours NIQ (NYSE: NIQ), a leading consumer intelligence company, today released its 2026 Environmental, Social and Governance (ESG) Progress Report, detailing the company’s progress on key ESG priorities throughout 2025. The report covers NIQ’s efforts across environmental responsibility, its people and communities, data integrity, and responsible AI. Key highlights from 2025 include:Strengthened its approach to climate risk and environmental measurement: NIQ conducted its first climate risk assessment aligned with Task Force on Climate-related Financial Disclosures (TCFD) recommendations, tracked Scope 1, 2 and 3 emissions under the GHG Protocol, and externally verified its carbon footprint. Invested in associate development, engagement and well-being: Internal mobility increased to 35%, up from 30%, while performance r
Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Demonstrating Deep Responses with Neoadjuvant BOT+BAL in Resectable Colon Cancer2.11.2026 12:42:00 CET | Press release
In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, including 29% pathologic complete response, within an overall 71% pathologic response rate after one BOT dose and two BAL dosesNo patients treated with BOT+BAL had their cancer return, with median follow-up of 19.2 months in MSS disease and 16.7 months in MSI-H disease; 12-month event-free survival was 100% in both combination cohorts.Independent, multicenter UNICORN findings reinforce the NEST peer-reviewed neoadjuvant evidence supporting Agenus’ planned Phase 3 ROBBIN trial in curative-intent MSS/pMMR colon cancer Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of results from the investigator-sponsored, multicenter Phase 2 UNICORN trial evaluating short-course preoperative, or neoadjuvant, botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, alone or in combination with ba
New Joint Survey from Compass Pathways and the Depression and Bipolar Support Alliance Reveals the Lived Burden of Treatment-Resistant Depression on Patients and Caregivers2.11.2026 12:30:00 CET | Press release
New survey findings reveal the extent of unmet need for people living with treatment-resistant depression (TRD) and its impact on families, relationships and the ability to participate fully in everyday life Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, in partnership with the Depression and Bipolar Support Alliance (DBSA), today released a new report summarizing findings from a national survey of people living with TRD (n=261) and caregivers (n=73) on the self-reported realities of living with a condition that can profoundly affect daily life, revealing the burden of prolonged depressive episodes without meaningful relief. The survey findings demonstrate the impact of TRD across various aspects of everyday life, with many patients reporting years spent cycling through treatments without significant improvement while the condition takes a toll on their hope, identity, relationships and ab
Qorium Becomes Reyva as Cultivated Leather Company Moves Towards Commercial Scale2.11.2026 11:00:00 CET | Press release
New identity signals the company’s evolution into a standalone material brand for luxury and automotive markets Reyva develops real leather by cultivating bovine collagen from a small sample of animal cells. The new brand brings together advanced biotechnology, leather expertise and a clearer luxury proposition. The company’s team, technology, partnerships and commercial ambition continue under the new name. Qorium, the company that develops cultivated real leather, today announces that it is becoming Reyva. The new name and identity mark its next stage: moving from a pioneering technology business towards a global material brand built for the exacting standards of the luxury leather sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261102661351/en/ Reyva creates beautiful, high-performing real leather. By cultivating leather in uniform sheets, we can move beyond the natural limits of traditional hides, with greater con
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom